Relates to coverage for treatments to slow the progression of Alzheimer's disease and related dementias

This bill requires insurance companies, health service corporations, and medical expense indemnity corporations to cover medically necessary diagnostic testing and FDA-approved treatments for Alzheimer's disease and related dementias. The coverage applies to all medical, major medical, or comprehensive-type insurance policies issued, renewed, or modified on or after the bill's effective date. Insurers must allow licensed physicians to determine the necessity of these treatments and cannot use step therapy to delay or deny coverage for FDA-approved medications prescribed to slow disease progression. The law directly affects individuals with Alzheimer's or related conditions who have health insurance in the state, ensuring their access to approved treatments without additional hurdles.